Voyager Therapeutics (VYGR) Current Leases: 2019-2025
Historic Current Leases for Voyager Therapeutics (VYGR) over the last 7 years, with Sep 2025 value amounting to $7.8 million.
- Voyager Therapeutics' Current Leases rose 12.45% to $7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.8 million, marking a year-over-year increase of 12.45%. This contributed to the annual value of $7.2 million for FY2024, which is 125.84% up from last year.
- As of Q3 2025, Voyager Therapeutics' Current Leases stood at $7.8 million, which was up 2.76% from $7.6 million recorded in Q2 2025.
- In the past 5 years, Voyager Therapeutics' Current Leases ranged from a high of $7.8 million in Q3 2025 and a low of $2.5 million during Q2 2022.
- Over the past 3 years, Voyager Therapeutics' median Current Leases value was $6.7 million (recorded in 2024), while the average stood at $5.6 million.
- As far as peak fluctuations go, Voyager Therapeutics' Current Leases plummeted by 49.17% in 2022, and later skyrocketed by 125.84% in 2024.
- Over the past 5 years, Voyager Therapeutics' Current Leases (Quarterly) stood at $5.6 million in 2021, then plummeted by 49.17% to $2.8 million in 2022, then rose by 12.99% to $3.2 million in 2023, then soared by 125.84% to $7.2 million in 2024, then increased by 12.45% to $7.8 million in 2025.
- Its last three reported values are $7.8 million in Q3 2025, $7.6 million for Q2 2025, and $7.4 million during Q1 2025.